Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details Narrative)

v3.22.2.2
Stockholders’ Equity (Details Narrative) - USD ($)
 9 Months Ended
Jun. 22, 2022
Sep. 30, 2022
Jun. 21, 2022
Jan. 23, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Number of shares vested   893,181    
Granted fair value vested   $ 8,858,382    
Number of stock repurchased   519,828    
Value of stock repurchased   $ 7,536,216    
Value of outstanding warrants   $ 38,583    
Closing share price   $ 9.10    
Grant date fair value   $ 9,512,356    
Granted fair value expensed   $ 653,974    
Maximum [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Stock repurchase authorized value       $ 10,000,000
Common Stock [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Number of shares vested   220,164    
Number of shares granted   908,362    
Shares vested   120    
Granted shares value   $ 2,009,657    
Number of unvested shares outstanding   15,181    
Unrecognized value of shares   $ 34,157    
Granted fair value vested   $ 495,369    
Common Stock [Member] | Employees, Consultants, and Directors [Member] | 2019 Equity Incentive Plan [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Shares granted 1,498,128      
Granted exercise price per share     $ 7.63